Eu2P EVENTS ARE NOT-TO-BE-MISSED OPPORTUNITIES


TO GET INSIGHTFUL INFORMATION IN PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLGY


Eu2P TALKS IN PRACTICE

Overview

Recent and on-going changes in the drug safety world put you in front of exciting but demanding new challenges. Real world data and real-world evidence are playing an increasing role in health care decisions.
You now have to ensure that you have up-to-date knowledge and skills, you fulfil regulatory expectations and you master practical implications, all this at the worldwide level.

Being involved in the field of Pharmacovigilance and Pharmacoepidemiology, you are at the heart of fruitful crossed exchanges between pharma companies, regulatory bodies and research organisations, with the common goal of improving patient safety, rational use of drugs and related regulations compliance.

For ten years, Eu2P has been familiar with joining industry and regulatory perspectives from all over the world, in order to stimulate varied and multi-focused debates relevant to you and to the different stakeholders' interests and needs.


Objectives

Join the Eu2P TALKS IN PRACTICE and be sure to be up-to-date and confident in Pharmacovigilance and Pharmacoepidemiology especially regarding the:

  • Real World Evidence and the impact on decision making
  • Role of the QPPV and the evolution of the Pharmacovigilance System Master File
  • New EudraVigilance (EV) system: Signal detection and access policy
  • Risk Management Plans
  • Surrogate endpoints
  • Pharmacoepidemiology in practice

Terms & Conditions

All cancellations must be made in writing and be received at the Eu2P office two weeks prior to the event start date.
Cancellations are subject to an administrative fee of 100€. If you do not cancel within deadline, you will be responsible for the full registration fee.

Eu2P reserves the right to alter the venue and dates if necessary. If an event is cancelled or postponed, Eu2P is not responsible for airfare, hotel or other costs incurred by registered attendees.

Please note that, by registering to this event, you agree being video-recorded from the back of the classroom and your questions or comments being audio-recorded. Likewise, you agree to be (partially) included in Eu2P pictures that may be taken during the event and published on Eu2P social networks. Please note that these pictures will not allow identifying you (They will be taken from the back of the classroom and/or not completely framing on your face).
You can read more info on Eu2P privacy policy on our website page.

 

Schedule


Format

The Eu2P TALKS IN PRACTICE format is designed to stimulate exchange of views and generate new ideas through informal talks (45 min) followed by workshops (45 min).


Public

Professionals and Eu2P Alumni who are willing to meet and share thoughts and practice with experts in key areas of drug safety: Signal detection · Decision making · New EudraVigilance · Risk Management Plan · Pharmacoepidemiology


Registration

  Professional Alumni
Eu2P TALKS IN PRACTICE 990 € 790 €
Eu2P TALKS IN PRACTICE - Day 1 490 € 390 €
Eu2P TALKS IN PRACTICE - Day 2 490 € 390 €

REGISTRATION CLOSED

NEED TO TALK TO US?

 

Eu2P TALKS IN PRACTICE - Day 1

 

Agenda

  • 09:00 AM - 10:30 AM
    Role of the QPPV and the evolution of the PSMF
    Presenter : Vijay Kara
  • Coffee Break - Networking
  • 11:00 AM -12:30 PM
    The New EudraVigilance (EV) System: Where are we now?
    Presenter : Vijay Kara
  • Lunch time
  • 05:00 PM - 06:30 PM
    Signal detection
    Presenter : Bruno Stricker
  • 03:00 PM - 04:30 PM
    RMP: the effects of inappropriate use of the target medicine
    Presenter : Olaf Klungel
  • 01:30 PM - 03:00 PM
    Risk Management
    Presenter : Kiki Cheung
 

Expert team


avatar

Prof. Olaf Klungel

Utrecht Universiteit

avatar

Prof. Bruno Stricker

Erasmus Universitair Medisch Centrum

avatar

Kiki Cheung

Erasmus Universitair Medisch Centrum

avatar

Vijay Kara

GlaxoSmithKline Research and Development Ltd

Eu2P TALKS IN PRACTICE - Day 2

 

Agenda

  • 09:00 AM - 10:30 AM
    Selecting outcomes: surrogate endpoints
    Presenter : Antònia Agustí
  • Coffee Break - Networking
  • 11:00 AM -12:30 PM
    Real World Evidences, measures, implications and impact on decision making
    Presenter : Albert Figueras
  • Lunch time
  • 02:00 PM - 03:30 PM
    Pharmacoepidemiology in practice
    Presenter : Bernard Bégaud
 

Expert team


avatar

Prof. Bernard Bégaud

Université de Bordeaux

avatar

Prof. Albert Figueras

Universitat Autònoma de Barcelona

avatar

Dr. Antònia Agustí

Universitat Autònoma de Barcelona

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners